Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
VERU INC. reports $38.8 million Q2 loss
By USInMinutes - May 11, 2023, 10:06 AM ET
Last Updated - Jul 18, 2023, 03:31 PM EDT
The company generated $6.60 million in quarterly revenue
VERU INC. [VERU] has reported fiscal Q2 loss of $38.80 million.
On a per-share basis, the WI based company said its diluted earnings are $0.48.
The Pharmaceutical Preparations firm posted revenue of $6.60 million in this period.
Also Read:
- Veru Reports Fiscal 2023 Second Quarter Financial Results
- Veru Reaches Agreement with FDA on Confirmatory Phase 3 Clinical Trial for Sabizabulin ...
- Blue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign Prostatic Hyperplasia Asset
- Veru Sells ENTADFI® Business for $20 Million Plus up to an Additional $80 Million from Sales ...
- Veru Enters Into Supply Agreement with Afaxys to Expand Access to FC2 Female Condom® in U.S. ...
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News